Organoids
Organoids are the Future of Predictive Human Medicine
Leading regulatory agencies worldwide are enacting legislation that promotes preclinical testing using advanced, human-relevant models instead of animals. Organoids have been named as a potential alternative. These innovative approaches offer more accurate and predictive results, paving the way for safer and more effective drugs to go to market and help patients in need.
What is an Organoid?
Organoids are miniature models of human organs, designed to recapitulate the organ’s structure and function in a dish.
Though small in size, organoids are highly complex and can be produced at scale, making them an ideal tool to predict how human organs will respond to drugs.
Why GastroScreen?
GastroScreen can be used to test drugs on human organs before going to human clinical trials, mitigating risk and reducing cost in clinical trials and identifying more promising compounds for patients in need.
How does GastroScreen compare to others on the market?
There are currently no other companies making stem cell-derived human intestinal organoids.
Our product is the only one made from human cells, comes from the highly scalable and tractable source of human stem cells, contains major cell types of the human intestine, is spatially organized in 3D and can mimic functions of the intestine.
Is GastroScreen patented?
- One patent pending – filed through the University of Michigan Innovation Partnerships (#US20220195395A1)
Which global regulatory agencies are addressing this challenge?
-
FDA Modernization Act 2.0 2022
-
EU Wide Phase-Out of Animal Testing
